Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.
about
Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virusA novel self-replicating chimeric lentivirus-like particleStructural determinants and mechanism of HIV-1 genome packagingEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoRole of the DIS hairpin in replication of human immunodeficiency virus type 1The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?Cross- and Co-Packaging of Retroviral RNAs and Their ConsequencesThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneA third-generation lentivirus vector with a conditional packaging systemInfectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.The bovine leukemia virus encapsidation signal is composed of RNA secondary structures.High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cellsA Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.Complementation of integrase function in HIV-1 virions.The inside out of lentiviral vectorsMapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.Inducible human immunodeficiency virus type 1 packaging cell linesA conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replicationTruncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cellsMutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization.Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Development of HIV vectors for anti-HIV gene therapy.A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Structural dynamics of retroviral genome and the packagingCharacterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function.Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader regionSuboptimal provirus expression explains apparent nonrandom cell coinfection with HIV-1.Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression.
P2860
Q24529091-37AB3ADD-F559-4AE3-A340-DDAC691CE4D5Q24611993-63ECD77A-8F19-443C-8BCE-AB27247DB38DQ24632055-AEB53865-14D7-468D-835D-5750131A1B3EQ24673792-5763ABFA-C20E-4B22-AB72-600AECBEEBA3Q24678656-3DE58400-CDFD-488F-ADC5-4FE471F69102Q24680551-AF4BD653-A4B2-4C1B-84BE-6491264603B3Q24682817-B4D6DCFE-5312-4CE4-BDCD-CC7E53768CEDQ24805927-136E2D57-F7C3-4549-B81F-0EB6DCF56794Q28066817-6F147180-AC7F-4602-B90D-E5DF9B9F5EBFQ28301200-90B31C79-090D-4C16-B803-F66114E8313CQ29616120-5DDBA326-5613-4DA0-BEFE-F17A577A9C45Q30430249-B68631FB-802C-4D71-8742-B3636401888AQ33652758-44E6011A-51D8-40BA-B680-2A9F3454C6F5Q33783331-6E0B89EB-E0FD-4617-BEA7-A1FEE79DC720Q33785302-3D196B95-1790-45A9-8006-7533CB5633F4Q33785662-9F2A64F4-DF28-4514-AC36-0DAB71BAE075Q33793274-987D69D7-B18B-4BC1-B297-9234162A9297Q33804963-9CF74AFA-1DFA-43CF-879F-414B03F11CF1Q33816167-97F43493-93AF-4E8B-95D6-C505137A055EQ33822142-3D83F160-A827-4ACA-96E5-CA395A17BF12Q33887343-82E3E094-4287-4565-A7DB-41BD7FBAE405Q34633466-B3C84EAB-CBCD-4555-A62F-7B4D7C426094Q34673247-20F9667F-D89B-4980-9F07-1D05E2CCE9C8Q35829334-B3CC0A88-5202-445A-8164-42A30423640AQ35864277-07F4A268-A0E8-4DD2-A218-0D0AC952105BQ35879394-0705CD2E-B4E8-4A34-ACF1-18891A19BE0EQ35882018-040A479C-D497-4837-ADCD-CFCC458D9967Q35882188-CC84BCB2-469D-435B-A9CE-117E100CFB4EQ35893976-0DD51AE6-832E-42DB-87A1-25AEABDB8773Q35943050-E9109D75-08BF-4790-B845-67CAF277DA7BQ36099054-DC25C8B9-2005-4137-9FE3-4A25A430D369Q37090592-13A468FE-B50E-4A49-BF49-9F2C3A1BBA88Q37251114-CF296CF1-65F5-4386-9F1F-2D91445B038CQ37251477-E48C0349-997B-40DC-AE26-FB99A4D1F806Q37311199-C560E287-98A8-4964-B22C-BC96E46A3BF1Q37974642-A6C027FB-5FBD-41F4-8353-9DFAFF8FB366Q38257666-69EE9C33-2F7E-4FAD-8885-4E31EFD93BD9Q39321671-1438DEDE-3996-4243-BDA6-63148C4D47EEQ39331577-94A53420-B65D-4F1B-8C1A-E4277B437629Q39455140-13735B60-0940-4763-8CB5-3EDBC6B597B3
P2860
Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@ast
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@en
type
label
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@ast
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@en
prefLabel
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@ast
Analysis in human immunodefici ...... ansfer into human lymphocytes.
@en
P2093
P2860
P1433
P1476
Analysis in human immunodefici ...... ransfer into human lymphocytes
@en
P2093
P2860
P304
P407
P577
1994-06-01T00:00:00Z